Demographic Characteristics and Survival With AIDS: Health Disparities in Chicago, 1993–2001
- 1 April 2009
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 99 (S1) , S118-S123
- https://doi.org/10.2105/ajph.2007.124750
Abstract
Objectives. We examined correlations between survival and race/ethnicity, age, and gender among persons who died from AIDS-related causes. Methods. We estimated survival among 11 022 persons at 12, 36, and 60 months after diagnosis with AIDS in 1993 through 2001 and reported through 2003 to the Chicago Department of Public Health. We estimated hazard ratios (HRs) by demographic and risk characteristics. Results. All demographic groups had higher 5-year survival rates after the introduction of highly active retroviral therapy (1996–2001) than before (1993–1995). The HR for non-Hispanic Blacks to Whites was 1.18 in 1993 to 1995 and 1.51 (P < .01) in 1996 to 2001. The HR for persons 50 years or older to those younger than 30 years was 1.63 in 1993–1995 and 2.28 (P < .01) in 1996–2001. The female-to-male HR was 0.90 in 1993–1995 and 1.20 (P < .02) in 1996–2001. Conclusions. The risk of death was higher for non-Hispanic Blacks and Hispanics than for non-Hispanic Whites. Interventions are needed to increase early access to care for disadvantaged groups.Keywords
This publication has 37 references indexed in Scilit:
- The Survival Benefits of AIDS Treatment in the United StatesThe Journal of Infectious Diseases, 2006
- Determinants of survival following HIV-1 seroconversion after the introduction of HAARTThe Lancet, 2003
- The Geographic Distribution of AIDS in the United States: Is There a Rural Epidemic?The Journal of Rural Health, 2000
- Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosisAIDS, 1999
- Combination Antiretroviral Therapy and Recent Declines in AIDS Incidence and MortalityThe Journal of Infectious Diseases, 1999
- Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapiesAIDS, 1999
- Effects of zidovudine therapy in minority and other subpopulations with early HIV infectionPublished by American Medical Association (AMA) ,1991
- A New Prognostic Staging System for the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea programJAMA, 1988
- Survival with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987